One Clinical Trial Management System for clinical development process and beyond. Evidence-based decisions. More information – less efforts.
Drop us a line and we be happy to answer all your questions
Clients
Daily users
Documents
Clinical trials
Countries
Every clinical trial role requires different information. CRAs need to track upcoming monitoring visits, Project Managers need study performance metrics, and clinical operations teams need enrollment and site activity data. In this video, see how Flex Databases CTMS allows every user to create a personalized dashboard without affecting other users. Learn how to add or […]
Managing Investigator Site Files across multiple sites is one of the more operationally demanding aspects of clinical trial oversight. Flex Databases addresses this with a dedicated ISF module built around three distinct user experiences (Sponsor, CRA, and Site) each tailored to the workflows and priorities of its audience. The Sponsor View: Study-Wide Visibility Sponsors access […]
When evaluating core clinical research platforms, most companies naturally start with the well-known enterprise brands. They are recognizable, widely adopted, and often positioned as the “safe choice” for regulated environments. But once the demo phase is over and implementation actually begins, many teams discover that choosing a platform involves much more than brand recognition and […]
CROs work in a fast-moving and highly complex environment. They manage multiple studies at the same time, often for different sponsors, across different countries, sites, and timelines. Each study comes with its own processes, reporting needs, and regulatory expectations. As this complexity grows, it becomes harder to keep everything aligned using separate tools or spreadsheets […]
Get in touch to discuss compliance, implementation, demos, pricing
We are here for all of your questions! Tell us more about yourself and we will organize a tailored live demo to show how you can power up your clinical trials processes with Flex Databases.